Key terms
About ADMA
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ADMA news
Yesterday
10:38am ET
Biotech Alert: Searches spiking for these stocks today
Apr 02
5:32pm ET
Kaitlin Kestenberg Promoted to COO at ADMA Biologics
Mar 26
6:17am ET
ADMA Biologics Poised for Robust Growth: Buy Rating Affirmed with Enhanced Price Target
Mar 11
7:19am ET
ADMA Biologics announces FDA approval of sBLAs for ASCENIV, BIVIGAM
Mar 01
7:28am ET
ADMA Biologics price target raised to $10 from $9 at Mizuho
Feb 29
6:43am ET
Buy Rating Affirmed for ADMA Biologics Amidst Strong Financial Growth and Positive Long-Term Outlook
Feb 28
4:44pm ET
ADMA Biologics Enhances Executive Compensation and Seeks New CFO
Feb 28
4:35pm ET
ADMA Biologics CFO Brian Lenz to transition out of role
Feb 28
4:31pm ET
ADMA Biologics ups FY24 revenue view to over $330M from $320M, consensus $315.3M
Feb 28
4:29pm ET
ADMA Biologics reports Q4 EPS (8c), consensus 2c
Feb 21
8:14am ET
ADMA Biologics Launches ADMAlytics AI Program
Feb 21
7:14am ET
ADMA Biologics successfully implements ADMAlytics
No recent press releases are available for ADMA
ADMA Financials
Key terms
Ad Feedback
ADMA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ADMA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
